Christopher Monroe's most recent trade in Texas Roadhouse Inc was a trade of 4,368 Common Stock done . Disclosure was reported to the exchange on Feb. 28, 2025.
Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
---|---|---|---|---|---|---|---|---|---|---|
Texas Roadhouse Inc | David Christopher Monroe | CHIEF FINANCIAL OFFICER | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 28 Feb 2025 | 4,368 | 9,710 (0%) | 0% | 0 | Common Stock | |
Texas Roadhouse Inc | David Christopher Monroe | CHIEF FINANCIAL OFFICER | Payment of exercise price or tax liability using portion of securities received from the company at price $ 177.90 per share. | 28 Feb 2025 | 1,755 | 7,955 (0%) | 0% | 177.9 | 312,215 | Common Stock |
Texas Roadhouse Inc | David Christopher Monroe | CHIEF FINANCIAL OFFICER | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 31 Dec 2024 | 2,300 | 0 | - | - | Restricted Stock Units | |
Texas Roadhouse Inc | David Christopher Monroe | CHIEF FINANCIAL OFFICER | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 31 Dec 2024 | 2,300 | 3,516 (0%) | 0% | 0 | Common Stock | |
Texas Roadhouse Inc | David Christopher Monroe | CHIEF FINANCIAL OFFICER | Payment of exercise price or tax liability using portion of securities received from the company at price $ 180.19 per share. | 31 Dec 2024 | 1,076 | 2,440 (0%) | 0% | 180.2 | 193,884 | Common Stock |
Texas Roadhouse Inc | Monroe David Christopher | CHIEF FINANCIAL OFFICER | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 23 Feb 2024 | 1,782 | 1,782 (0%) | 0% | 0 | Common Stock | |
Texas Roadhouse Inc | Christopher Monroe David | CHIEF FINANCIAL OFFICER | Payment of exercise price or tax liability using portion of securities received from the company at price $ 149.03 per share. | 23 Feb 2024 | 566 | 1,216 (0%) | 0% | 149.0 | 84,351 | Common Stock |
Texas Roadhouse Inc | Christopher David Monroe | CHIEF FINANCIAL OFFICER | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 08 Jan 2024 | 4,200 | 4,200 | - | - | Restricted Stock Units | |
IonQ Inc | Christopher Monroe | Chief Scientist | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 15 Aug 2023 | 41,716 | 3,897,970 | - | 0 | Common Stock | |
IonQ Inc | Christopher Monroe | Chief Scientist | Sale of securities on an exchange or to another person at price $ 10.75 per share. | 25 May 2023 | 200,000 | 3,856,254 | - | 10.8 | 2,150,000 | Common Stock |
IonQ Inc | Christopher Monroe | Chief Scientist | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 24 May 2023 | 8,667 | 4,058,934 | - | 0 | Common Stock | |
IonQ Inc | Christopher Monroe | Chief Scientist | Sale of securities on an exchange or to another person at price $ 4.43 per share. | 12 Dec 2022 | 1,608 | 6,617,040 | - | 4.4 | 7,123 | Common Stock |
IonQ Inc | Christopher Monroe | Chief Scientist | Sale of securities on an exchange or to another person at price $ 5.44 per share. | 12 Sep 2022 | 1,548 | 6,618,648 | - | 5.4 | 8,421 | Common Stock |
IonQ Inc | Christopher Monroe | Chief Scientist | Sale of securities on an exchange or to another person at price $ 5.44 per share. | 12 Sep 2022 | 1,548 | 4,050,267 | - | 5.4 | 8,421 | Common Stock |
IonQ Inc | Christopher Monroe | Chief Scientist | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 18 Aug 2022 | 128,534 | 128,534 | - | - | Employee Stock Option (right to buy) | |
IonQ Inc | Christopher Monroe | Chief Scientist | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 18 Aug 2022 | 86,058 | 6,620,196 | - | 0 | Common Stock | |
IonQ Inc | Christopher Monroe | Chief Scientist | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 30 Sep 2021 | 6,534,138 | 6,534,138 | - | 0 | Common Stock | |
IonQ Inc | Christopher Monroe | Chief Scientist | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 30 Sep 2021 | 1,214,535 | 1,214,535 | - | - | Employee Stock Option (right to buy) | |
IonQ Inc | Christopher Monroe | Chief Scientist | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 30 Sep 2021 | 404,845 | 404,845 | - | - | Employee Stock Option (right to buy) | |
IonQ Inc | Christopher Monroe | Chief Scientist | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 30 Sep 2021 | 246,684 | 246,684 | - | - | Employee Stock Option (right to buy) |